###### Strengths and limitations of this study

-   This study examined the association between an indicator of the overall nutritional quality of the diet based on the Food Standards Agency Nutrient Profiling System (FSA-NPS DI) and the incidence of breast cancer using data from a large prospective cohort study, NutriNet-Santé.

-   Dietary intakes were assessed using repeated 24-hour dietary records based on a recent food composition database with a large choice of items (\>3300) allowing a better insight into the food products consumed and their intrinsic nutritional composition.

-   Unlike other a priori scores, components of the FSA-NPS DI cannot be studied separately since the FSA-NPS DI is first calculated at the food level (FSA-NPS) and then aggregated at the individual level. In addition, the calculation of the FSA-NPS score ([online supplementary file 1](#SP1){ref-type="supplementary-material"}) is based on thresholds and is conditional. Thus, the specific contribution of each component of the FSA-NPS DI score to breast cancer risk could not be studied.

-   This study included volunteers involved in a long-term cohort study investigating the association between nutrition and health, with overall more health-conscious behaviours and higher professional and/or educational level compared with the general population so that unhealthy dietary behaviours may have been under-represented.

-   This study was based on self-declared dietary intakes and on an observational cohort, thus residual confounding cannot be ruled out even though a lot of potential confounders were taken into account.
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Introduction {#s1}
============

Breast cancer is the most common female cancer worldwide, with 1.7 million new cases diagnosed in 2012, representing 25% of all cancers.[@R1] According to the estimations of the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR), around one-third of breast cancers could be avoided with appropriate diet, body fatness and physical activity.[@R2]

Nutrition has therefore the potential to be a key factor in breast cancer prevention since it can be modified at the individual level and thus can be targeted by public health policies. To help consumers make healthier food choices, several scientific organisations worldwide have recommended the implementation of a simplified nutrition labelling system on the front-of-pack of food products.[@R3] In France, a five-colour labelling system (Five-Colour Nutrition Label (5-CNL)) based on the British Food Standards Agency Nutrient Profiling System (FSA-NPS)[@R8] has been proposed to summarise the overall nutritional quality of food products.[@R10] The FSA-NPS attributes a single score to food products based on a limited number of input variables: amount per 100 g of energy, total sugars, saturated fatty acids (SFAs), sodium, fruits and vegetables, dietary fibres and proteins. This scoring system was initially developed and validated in the UK, where it is used for advertising regulation,[@R8] and it has been adapted and validated in the French context.[@R13] At the individual level, the nutritional quality of the diet can be characterised with a dietary index based on the FSA-NPS (FSA-NPS DI). The FSA-NPS DI has been associated to food and nutrient intakes, nutritional status and adherence to the French nutritional recommendations.[@R17]

To evaluate the relevance and potential public health impact of the 5-CNL adoption, it is important to assess whether there is a relationship between the nutritional quality of food choices at the individual level, as graded by the FSA-NPS DI, and the occurrence of nutrition-related chronic diseases. To our knowledge, our group was the first to investigate the associations between the FSA-NPS DI and health outcomes. Using prospective designs, studies were conducted in the SU.VI.MAX cohort (13 017 participants, 1994--2007) on the associations between the FSA-NPS DI and 13-year weight gain/obesity onset,[@R19] metabolic syndrome,[@R20] cardiovascular diseases[@R21] and cancer.[@R22] A higher FSA-NPS DI, reflecting a diet of lower nutritional quality, was associated with an increased risk for all the studied outcomes and, in particular, with an increased risk of cancer overall.[@R22] No significant association with breast cancer risk was detected in this study,[@R22] but the statistical power was limited for site-specific analyses (n=125 breast cancer cases).

Thus, our objective was to study the association between the FSA-NPS DI (an indicator of the nutritional quality of the diet based on a nutrient profiling system) and breast cancer risk, using data from NutriNet-Santé, a large prospective cohort with up-to-date assessment of dietary intakes.

Methods {#s2}
=======

Study population {#s2a}
----------------

The NutriNet-Santé study is an  ongoing French web-based cohort launched in 2009 with the objective to study the associations between nutrition and health as well as the determinants of dietary behaviours and nutritional status. This cohort has been previously described in details.[@R23] Participants aged ≥18 years with access to the Internet are continuously recruited since May 2009 among the general population by means of vast multimedia campaigns. All questionnaires are completed online through a dedicated website ([www.etude-nutrinet-sante.fr](www.etude-nutrinet-sante.fr)). The NutriNet-Santé study is conducted according to the Declaration of Helsinki guidelines and was approved by the Institutional Review Board of the French Institute for Health and Medical Research (IRB Inserm n°0000388FWA00005831) and the 'Commission Nationale de l'Informatique et des Libertés' (CNIL n°908450/n°909216). Electronic informed consent is obtained from each participant (EudraCT no.2013-000929-31).

Data collection {#s2b}
---------------

At inclusion, participants fulfilled a set of five questionnaires on sociodemographic and lifestyle characteristics[@R24] (eg, occupation, educational level, smoking status, alcohol consumption and number of children), anthropometrics[@R25] (eg, height, weight), dietary intakes (see below), physical activity (validated IPAQ questionnaire)[@R27] and health status (eg, personal and family history of diseases, medication use including hormonal treatment for menopause and oral contraception and menopausal status). Follow-up of participants began when participants answered their last baseline questionnaire. The date of completion of the last baseline questionnaire is thus used as inclusion date. Participants are then invited to complete these five baseline questionnaires every year as part of the follow-up.

Dietary intakes were assessed at baseline and every 6 months through series of three non-consecutive validated web-based 24-hour dietary records, randomly assigned over a 2-week period (two weekdays and one weekend day).[@R28] Thus, over the first 2 years of follow-up, up to five series of three 24-hour dietary records could have been completed. To be considered as valid, a series must have included at least two out of three 24-hour dietary records. Participants used a dedicated interface of the study website to declare all foods and beverages consumed during a 24-hour period: three main meals (breakfast, lunch and dinner) or any other eating occasion. Portion sizes were estimated using validated photographs.[@R31] Mean daily energy, alcohol and nutrient intakes were estimated using a published French food composition table (\>3300 items)[@R32] and a weighting for weekdays and weekend days. Amounts consumed from composite dishes were estimated using French recipes validated by food and nutrition professionals. Dietary under-reporting was identified on the basis of the method proposed by Black.[@R33]

FSA-NPS DI computation {#s2c}
----------------------

As described previously,[@R9] the FSA-NPS score for all foods (processed and unprocessed) and beverages was computed based on the nutrient content for 100 g. FSA-NPS scores for foods and beverages are based on a discrete continuous scale from −15 (most healthy) to +40 (less healthy) (online s[upplementary file 1](#SP1){ref-type="supplementary-material"}). FSA-NPS score allocates points (0--10) for the amount of energy (kJ), total sugar (g), SFA (g) and sodium (mg). Points (0--5) are subtracted from the previous sum based on the amount of fruits and vegetables (%, including legumes and nuts), fibres (g) and proteins (g). Specific modifications of the score for particular food groups were made to maintain a high consistency with French nutritional recommendations, as proposed by the French High Council for Public Health.[@R34]

In a second step, the FSA-NPS DI was computed at the individual level using arithmetic energy-weighted means with the following equation,[@R17] in which FS~i~ represents the food (or beverage) score, and E~i~ represents the energy intake from this food or beverage (all 24-hour dietary records from the first 2 years of follow-up were averaged to a mean 24 hours energy intake from this food/beverage):

$$\text{FSA} - \text{NPS\ DI} = \frac{\sum\limits_{\text{i} = 1}^{\text{n}}\text{FS}_{\text{i}}\text{E}_{\text{i}}}{\sum\limits_{\text{i} = 1}^{\text{n}}\text{E}_{\text{i}}}$$

Increasing FSA-NPS DI reflects decreasing nutritional quality of foods consumed.

Case ascertainment {#s2d}
------------------

Participants self-declared health events through the yearly health status questionnaire, through a specific check-up questionnaire for health events (every 3 months) or at any time through a dedicated interface on the study website. Following this declaration, participants are invited to send their medical records (diagnosis, hospitalisation and so on) and, if necessary, the study physicians contact the participants' treating physician or the medical structures to collect additional information. Then, data are reviewed by an independent physician expert committee, which validates all major health events (such as cancers). Cancer cases were classified using the International Chronic Diseases Classification, 10th Revision, Clinical Modification.[@R35] In this study, all first primary breast cancers diagnosed between the inclusion and August 2015 were considered as cases. Information on death and cause of death was obtained through linkage to the national database on mortality of the French population.[@R36]

Statistical analyses {#s2e}
--------------------

So far, 77 034 women without cancer at baseline provided at least three valid 24-hour dietary records during their first 2 years of follow-up. Women aged \<35 years at baseline (n=29 249) were excluded due to a very low susceptibility to develop breast cancer in these women[@R37] and a potentially limited influence of nutrition on breast cancers diagnosed in young women. Women with a null follow-up were also excluded from the analyses (ie, women for whom baseline questionnaires were the last completed questionnaires, n=921), thus leaving 46 864 women included in the analyses (flowchart in online s[upplementary file 2](#SP2){ref-type="supplementary-material"}).

10.1136/bmjopen-2016-013718.supp2

###### Supplementary material 2

For each woman, the FSA-NPS DI and usual dietary intakes were calculated using all 24-hour dietary records available in their first 2 years of follow-up. Associations between the FSA-NPS DI (continuous variable and quintiles) and breast cancer risk were characterised (HR and 95% CI) using multivariable Cox proportional hazards models with age as the primary time variable. We confirmed that the assumptions of proportionality were satisfied through examination of the log--log (survival) versus log--time plots. Tests for linear trends were performed with the ordinal score on quintiles of FSA-NPS DI. Women contributed person-time to the model until the date of cancer diagnosis, the date of last completed questionnaire and the date of death or August 2015, whichever occurred first. Women who reported cancer other than breast cancer during the study period were included and censored at the date of diagnosis (except basal cell skin carcinoma, not considered as cancer).

Models were adjusted for classic risk factors for breast cancer: age (timescale), body mass index (BMI) (kg/m². continuous), height (cm, continuous), physical activity (high, moderate, low, computed following IPAQ recommendations[@R38]), smoking status (never smokers, former smokers, occasional smokers and smokers), number of dietary records (continuous), alcohol intake (g/d, continuous), energy intake (without alcohol, g/d, continuous), family history of cancer (yes/no), educational level (\<high school degree, \<2 years after high school degree and ≥2 years after high school degree), number of biological children (continuous), menopausal status at baseline (premenopause, perimenopause and postmenopause), hormonal treatment for menopause (postmenopausal women, yes/no) and oral contraception use (premenopausal women, yes/no).

Interaction analysis was conducted between BMI and the FSA-NPS DI, and stratified analyses were performed by overweight status (BMI \< vs ≥25 kg/m^2^).

Sensitivity analyses were performed including only women that provided at least six 24-hour dietary records during their first 2 years of follow-up or excluding cases diagnosed during their first year of follow-up. Analyses were also performed on invasive breast cancer cases only, by hormonal receptor status of the tumours and by menopausal status. For the latter, women contributed person-time to the 'pre-menopause model' until their age of menopause and to the 'post-menopause model' from their age of menopause. Age at menopause was determined using the yearly health status questionnaires available during the follow-up.

For all covariates except physical activity, ≤5% of values were missing and were imputed to the modal value. For physical activity (n=6328 missing values), a 'missing class' was introduced into the models.

All tests were two sided, and p\<0.05 was considered statistically significant. SAS V.9.4 was used for the analyses.

Results {#s3}
=======

Between May 2009 and August 2015 (median follow-up time: 4.0 years; 174 491 person-years), 555 incident breast cancer cases were diagnosed: 171 premenopausal and 384 postmenopausal; 71.4% ER+/PR+, 14.7% estrogen receptor (ER)−/progesterone receptor (PR)−, 13.6% ER+/PR−, 0.3% ER−/PR+ (data available for 361 cases); 83.6% invasive and 16.4% in situ (data available for 463 cases). Mean age at diagnosis was 56.6 years (SD=9.2) and mean baseline-to-diagnosis time was 2.4 years (SD=1.6). Mean number of dietary records per participant over their first 2 years of follow-up was 5.9 (SD=2.8).

In [table 1](#T1){ref-type="table"}, the characteristics of participants at baseline are described overall and by quintiles of the FSA-NPS DI. Mean FSA-NPS DI was 5.9 (SD=2.2; min=−5.8; max=18.1). Women with a higher FSA-NPS DI (diet of lower nutritional quality) were more likely to be young, to smoke, to have a higher educational level and to have higher energy or alcohol intakes. As expected, women in the lowest quintiles of FSA-NPS DI (diet of higher nutritional quality) had overall healthier food intakes: higher intakes of fibre, fruits, vegetables, legume and fish and lower intakes of red and processed meat and lipids.

###### 

Baseline characteristics of the study population overall and according to quintiles of the FSA-NPS DI, NutriNet-Santé Cohort, France, 2009--2015

                                                                               Quintiles of the FSA-NPS DI                                                           
  ------------------------------------------------------------ --------------- ----------------------------- ------------- ------------- ------------- ------------- ----------
  FSA-NPS DI                                                   5.9±2.2         2.7±1.2                       4.8±0.4       6.0±0.3       7.1±0.4       9.0±1.1       \<0.0001
  Age, years                                                   50.8±9.7        53.4±9.6                      52.6±9.4      51.2±9.7      49.6±9.4      47.1±8.9      \<0.0001
  Educational level                                                                                                                                                  \<0.0001
   \< High school degree                                       11 269 (24.1)   2658 (28.4)                   2345 (25.0)   2172 (23.1)   2083 (22.1)   2011 (21.6)   
   ≥High school degree to \<2 years after high school degree   7834 (16.7)     1567 (16.8)                   1579 (16.8)   1570 (16.7)   1556 (16.5)   1562 (16.8)   
   ≥2 years after high school degree                           27 761 (59.2)   5124 (54.8)                   5471 (58.2)   5645 (60.1)   5776 (61.3)   5745 (61.6)   
  Smoking status                                                                                                                                                     \<0.0001
   Non-smokers                                                 22 528 (48.1)   4630 (49.5)                   4706 (50.1)   4615 (49.2)   4504 (47.8)   4073 (43.7)   
   Former smokers                                              17 904 (38.2)   3744 (40.0)                   3640 (38.7)   3561 (37.9)   3527 (37.5)   3432 (36.8)   
   Occasional smokers†                                         1622 (3.5)      257 (2.7)                     302 (3.2)     336 (3.6)     350 (3.7)     377 (4.0)     
   Smokers                                                     4810 (10.3)     718 (7.7)                     747 (7.9)     875 (9.3)     1034 (11.0)   1436 (15.4)   
  Physical activity‡                                                                                                                                                 0.08
   Low                                                         13 955 (34.4)   3312 (41.1)                   2979 (36.4)   2800 (34.5)   2569 (31.5)   2295 (28.6)   
   Moderate                                                    17 062 (42.1)   3224 (40.0)                   3462 (42.4)   3487 (43.0)   3522 (43.2)   3367 (41.9)   
   High                                                        9519 (23.5)     1521 (18.9)                   1732 (21.2)   1829 (22.5)   2066 (25.3)   2371 (29.5)   
  BMI, kg/m²                                                   24.1±4.8        24.5±4.9                      24.1±4.7      23.9±4.5      23.9±4.6      24.3±5.2      \<0.0001
  Weight status                                                                                                                                                      \<0.0001
   Normalweight (BMI \<25 kg/m^2^)                             31 769 (67.8)   5929 (63.4)                   6406 (68.2)   6558 (69.9)   6550 (69.6)   6326 (67.9)   
   Overweight (25≤BMI\<30 kg/m^2^)                             9975 (21.3)     2270 (24.3)                   2002 (21.3)   1971 (21.0)   1924 (20.4)   1808 (19.4)   
   Obese (BMI ≥30 kg/m^2^)                                     5120 (10.9)     1150 (12.3)                   987 (10.5)    858 (9.1)     941 (10.0)    1184 (12.7)   
  Height, cm                                                   163.4±6.1       162.8±6.0                     163.0±6.0     163.4±6.1     163.7±6.0     164.2±6.1     \<0.0001
  Number of biological children                                1.8±1.2         1.8±1.2                       1.8±1.1       1.8±1.1       1.8±1.1       1.8±1.2       \<0.0001
  Family history of cancer (yes)                               21 158 (45.2)   4446 (47.6)                   4393 (46.8)   4288 (45.7)   4185 (44.4)   3846 (41.3)   0.9
  Menopausal status                                                                                                                                                  0.5
   Premenopause                                                23 940 (51.1)   3767 (40.3)                   4078 (43.4)   4637 (49.4)   5296 (56.2)   6162 (66.1)   
   Perimenopause                                               3997 (8.5)      807 (8.6)                     871 (9.3)     807 (8.6)     795 (8.4)     717 (7.7)     
   Postmenopause                                               18 927 (40.4)   4775 (51.1)                   4446 (47.3)   3943 (42.0)   3324 (35.3)   2439 (26.2)   
  Hormonal treatment for menopause use (yes)§                  4068 (17.7)     1025 (18.4)                   978 (18.4)    806 (17.0)    732 (17.8)    527 (16.7)    0.04
  Energy intake without alcohol, kcal/d                        1710±385        1510±331                      1648±334      1721±344      1792±370      1882±429      \<0.0001
  Alcohol intake, g/d                                          6.5±9.1         4.5±7.7                       5.9±8.4       6.8±9.0       7.4±9.5       7.9±10.5      \<0.0001
  Lipid intake, g/d                                            76.2±22.6       58.5±17.4                     70.2±17.4     76.9±18.2     83.0±19.7     92.4±23.9     \<0.0001
  Protein intake, g/d                                          76.0±18.3       78.1±20.6                     76.3±17.7     75.8±17.1     75.6±17.4     74.4±18.4     \<0.0001
  Carbohydrate intake, g/d                                     94.9±31.9       88.0±34.5                     94.6±31.5     96.3±30.4     98.1±30.9     97.3±31.0     \<0.0001
  Fibre intake, g/d                                            19.4±6.5        22.4±7.9                      20.5±6.2      19.4±5.7      18.4±5.4      16.6±5.2      \<0.0001
  Fruit intake, g/d                                            247.8±152.3     303.9±185.3                   271.1±145.8   249.6±138.2   226.7±130.9   187.4±128.0   \<0.0001
  Vegetable intake, g/d                                        236.6±113.3     295.8±138.5                   255.6±105.7   234.9±98.7    215.2±92.1    181.4±91.0    \<0.0001
  Legume intake, g/d                                           11.6±21.4       16.8±29.4                     12.7±21.3     11.0±19.1     9.7±17.9      7.6±15.7      \<0.0001
  Red meat intake, g/d                                         39.0±34.1       38.6±37.8                     39.6±33.3     40.0±33.8     40.0±32.8     39.7±31.0     \<0.0001
  Processed meat intake, g/d                                   28.4±25.7       19.4±21.9                     23.6±21.8     27.3±22.7     32.1±24.8     37.0±32.6     \<0.0001
  Poultry intake, g/d                                          24.8±27.6       31.3±34.6                     26.0±27.6     24.1±25.3     22.6±24.1     20.1±23.5     \<0.0001
  Fish (including sea product) intake, g/d                     40.7±37.6       52.2±45.2                     44.8±37.7     40.2±35.3     36.0±32.8     30.5±31.7     \<0.0001
  Dairy intake, g/d                                            162.8±145.3     217.2±176.1                   178.1±145.8   158.8±134.8   142.1±125.2   117.9±117.8   \<0.0001

\*p Value for the comparison between quintiles of FSA-NPS DI by χ² tests from age-adjusted ordinal polytomous logistic regressions.

†Occasional smokers smoke less than once a day.

‡Data available for 40 536 women.

§Among women in perimenopause or postmenopause (n=22 924).

FSA-NPS DI, British Food Standards Agency Nutrient Profiling System dietary index.

Compared to women who provided at least three 24-hour dietary records during their first 2 years of follow-up, women who did not (15 918 women with a non-null follow-up) were younger, premenopause, were more likely to be overweight/obese, to smoke, to practice physical activity and were less likely to have a family history of cancer or to take a hormonal treatment for menopause (data not tabulated).

Associations between the FSA-NPS DI and breast cancer risk overall and by menopausal status are shown in [table 2](#T2){ref-type="table"}. A direct association was observed between the FSA-NPS DI and breast cancer risk: HR~Q5vs.Q1~=1.52 (95% CI 1.11 to 2.08), p trend=0.002; HR~per\ 1-unit\ increment~=1.06 (1.02--1.11), p=0.005. These associations were similarly observed in premenopausal women (HR~Q5vs.Q1~=2.46 (1.27--4.75), p trend=0.004; HR~per\ 1-unit\ increment~=1.09 (1.01--1.18), p=0.03) and in postmenopausal women (HR~Q5vs.Q1~=1.25 (0.85--1.84), p trend=0.09; HR~per\ 1-unit\ increment~=1.05 (1.00--1.11), p=0.06), although the associations seemed stronger for premenopausal women and only trends were observed for postmenopausal women (p interaction=0.06).

###### 

Associations between the FSA-NPS DI and breast cancer risk, from multivariable Cox proportional hazards models, NutriNet-Santé Cohort, France, 2009--2015

                                       Age-adjusted model   Multivariable-adjusted model\*                                
  ----------------------- ------------ -------------------- -------------------------------- -------- ------ ------------ -------
  Overall                                                                                                                 
  Continuous score        555/46 309   1.07                 1.03 to 1.11                     0.001    1.06   1.02, 1.11   0.005
  Quintiles†                                                                                 0.0004                       0.002
  Q1                      82/9267      1.00                 (ref)                                     1.00   (ref)        
  Q2                      122/9273     1.44                 1.09 to 1.90                              1.43   1.08, 1.90   
  Q3                      117/9270     1.45                 1.09 to 1.93                              1.43   1.07, 1.91   
  Q4                      138/9277     1.83                 1.39 to 2.40                              1.79   1.35, 2.38   
  Q5                      96/9222      1.56                 1.15 to 2.10                              1.52   1.11, 2.08   
  Premenopausal women‡                                                                                                    
  Continuous score        171/23 483   1.09                 1.02 to 1.18                     0.02     1.09   1.01, 1.18   0.03
  Quintiles†                                                                                 0.002                        0.004
  Q1                      12/3667      1.00                 (ref)                                     1.00   (ref)        
  Q2                      28/3982      1.96                 0.99 to 3.85                              1.92   0.97, 3.79   
  Q3                      31/4558      1.94                 0.99 to 3.78                              1.89   0.96, 3.71   
  Q4                      52/5204      2.88                 1.53 to 5.39                              2.76   1.45, 5.26   
  Q5                      48/6072      2.52                 1.34 to 4.76                              2.46   1.27, 4.75   
  Postmenopausal women‡                                                                                                   
  Continuous score        384/27 188   1.06                 1.01 to 1.11                     0.02     1.05   1.00, 1.11   0.06
  Quintiles†                                                                                 0.03                         0.09
  Q1                      70/6416      1.00                 (ref)                                     1.00   (ref)        
  Q2                      94/6173      1.35                 0.99 to 1.84                              1.36   0.99, 1.86   
  Q3                      86/5578      1.38                 1.01 to 1.90                              1.37   0.99, 1.89   
  Q4                      86/5028      1.60                 1.17 to 2.20                              1.57   1.13, 2.18   
  Q5                      48/3993      1.30                 0.90 to 1.88                              1.25   0.85, 1.84   

\*Models were adjusted for age (timescale), BMI (kg/m², continuous), height (cm, continuous), physical activity (high, moderate and low), smoking status (never smokers, former smokers, occasional smokers and smokers), numbers of dietary records (continuous), alcohol intake (g/d, continuous), energy intake (without alcohol, g/d, continuous), family history of cancer (yes/no), educational level (\<high school degree, \<2 years after high school degree, ≥2 years after high school degree), number of biological children (continuous), menopausal status at baseline (premenopause, perimenopause and postmenopause), hormonal treatment for menopause (postmenopausal women, yes/no) and oral contraception use (premenopausal women, yes/no).

†Cut-offs for quintiles of the FSA-NPS DI were 4.1/5.4/6.5/7.7.

‡p for interaction between the FSA-NPS DI and menopausal status=0.06.

BMI, body mass index; FSA-NPS DI, British Food Standards Agency Nutrient Profiling System dietary index.

Analyses performed by overweight status showed that associations tended to be stronger in non-overweight women (368 cases/31 401 non-cases, HR~Q5vs.Q1~=1.97 (95% CI 1.31 to 2.96), p trend=0.0007; HR~per\ 1-unit\ increment~=1.09 (1.03--1.15), p=0.003) compared with overweight/obese women (187 cases/14 908 non-cases, HR~Q5vs.Q1~=1.02 (95% CI 0.61 to 1.73), p trend=0.6; HR~per\ 1-unit\ increment~=1.03 (0.95--1.11), p=0.5), but the interaction was not statistically significant (p=0.07).

Information regarding hormone receptor status was not available for all cases (ER status: 361 cases, PR status: 362 cases, ER/PR status: 361 cases). Significant direct associations between the FSA-NPS DI and breast cancer risk were observed for breast cancer types PR− (102 cases/46 762 non-cases) and ER+/PR− (49 cases/46 815 non-cases). For ER+ tumours, the linear trend was not statistically significant (p=0.07, 307 cases/46 557 non-cases) but compared with women in the lowest quintile of FSA-NPS DI, those with higher scores had an increased breast cancer risk (eg, HR~Q5vs.Q1~=1.60 (1.04--1.46)). Associations were non-significant for the other hormone receptor status ([online supplementary file 3](#SP3){ref-type="supplementary-material"}). However, these exploratory findings should be considered with caution due to limited statistical power for analyses by cancer subtypes.
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Similar results were observed when analyses excluded cases diagnosed during their first year of follow-up (425 cases/46 309 non-cases included; HR~Q5vs.Q1~=1.54 (1.08--2.19), p trend=0.007; HR~per\ 1-unit\ increment~=1.07 (1.02--1.12), p=0.01) or when analyses were restricted to invasive breast cancers (387 cases/46 309 non-cases; HR~Q5vs.Q1~=1.51 (1.03--2.22), p trend=0.01; HR~per\ 1-unit\ increment~=1.06 (1.01--1.12), p=0.03).

Results were also similar when analyses were restricted to women that provided at least six 24-hour dietary records during their first 2 years of follow-up (399 cases/25 439 non-cases; HR~Q5vs.Q1~=1.63 (1.11--2.38), p trend=0.006; HR~per\ 1-unit\ increment~=1.08 (1.02--1.14), p=0.01) (data not tabulated).

Finally, similar but weaker trends were observed when women aged \<35 years at baseline were included in the analyses (585 cases/74 617 non-cases, HR~Q5vs.Q1~=1.17 (95% CI 0.83 to 1.64), p trend=0.1; HR~per\ 1-unit\ increment~=1.05 (1.01--1.10), p=0.02).

Discussion {#s4}
==========

In this prospective study conducted in a large sample of women from the French general population, a higher FSA-NPS DI, which reflects a diet composed of food products of lower nutritional quality, was associated with a 52% increase in breast cancer risk (highest vs lowest quintile of the FSA-NPS DI score).

In a previous study performed in the SU.VI.MAX cohort,[@R22] we observed a direct association between the FSA-NPS DI and cancer risk overall but did not detect a significant association for breast cancer risk, probably due to limited power in site-specific analyses (n=125 breast cancer cases, 13-year follow-up). To our knowledge, no other study investigated the relationship between breast cancer risk and a score that characterises the nutritional quality of an individual's diet based on a nutrient profiling system at the level of foods/beverages consumed.

However, a few studies have been conducted on the association between NPS-based dietary scores and other health outcomes. While in this study, we used the FSA-NPS as a continuous score at the food/beverage level as a basis for the construction of the FSA-NPS DI at the individual level; the FSA-NPS was also recently used to define a variety score of 'healthier' and 'less healthy' foods/beverages (Ofcom binary cut-off used for advertising regulation in the UK[@R12]). This binary indicator was then studied in relation to mortality in the Whitehall II cohort.[@R39] The authors observed that a greater variety of healthier foods, as defined with the FSA-NPS Ofcom binary cut-off, was associated with a reduced all-cause and cancer mortality while a greater variety of less healthy food was not associated with the studied outcomes. No association was observed when another nutrient profiling system, the SAIN,LIM,[@R40] was used.[@R39]

To our knowledge, the Overall Nutritional Quality Index (ONQI-f) is the only other dietary score based on a nutrient profiling system that has been studied in relation to health outcomes.[@R42] It was tested in association with chronic diseases and mortality within the Nurses' Health Study and the Health Professionals Follow-up Study.[@R42] A higher ONQI-f, reflecting a higher nutritional quality of the diet, was associated with a decreased risk of cardiovascular diseases, diabetes and mortality but was not associated with cancer. Some arguments may explain this lack of association: (1) the ONQI-f is based on 30 nutrients among which few have shown a consistent association with cancer risk, thus, its relevance regarding the cancer outcome may be lower than for other outcomes; (2) dietary intakes were assessed with an aggregated food frequency questionnaire (135--138 items), which provides less precise estimates than 24-hour dietary records (as used in our study).

These studies are, to our knowledge, the only ones that investigated the associations between health outcomes and individual dietary indexes derived from nutrient profiling systems at the food level. Other a priori scores have been designed based on the intake of specific food groups or nutrients and/or other information (eg, body fatness and physical activity), but not based on a nutrient profiling system at the food/beverage level. These scores were studied prospectively in relation to breast cancer risk and provided relatively contrasted results: (1) scores measuring the adherence to a specific type of diet such as the Mediterranean diet score (no association in prospective cohorts, inverse association in case--control studies[@R43]) or the Healthy Nordic Food Index (no association[@R46]), (2) scores reflecting the adherence to general nutritional recommendations for the population such as the WHO Healthy Diet Index[@R47] the Alternate Healthy Eating Index (AHEI),[@R45] the Recommended Food Score (RFS),[@R48] the Diet Quality Index revised[@R48] or the Dietary Approaches to Stop Hypertension (DASH)[@R45] (no association overall) and (3) scores measuring the adherence to cancer-specific nutritional recommendations such as the WCRF/AICR adherence score (inverse associations[@R49]) or the American Cancer Society cancer prevention guidelines score (inverse association[@R51]). In these studies, differences according to hormonal receptor status of the tumours have been suggested, with inconsistent results. Indeed, inverse associations between a 'healthier' diet and breast cancer risk were particularly observed in ER− type (AHEI, RFS and aMed),[@R48] ER−/PR+ type (Mediterranean diet score)[@R43] and ER−/PR−/HER2+ type (DASH),[@R45] but also with ER+/PR+ type (WCRF/AICR adherence score)[@R49] and ER+/PR− type ('healthy/Mediterranean' pattern).[@R52] In our study, information regarding hormonal receptor status of the tumours was only partially available, and the statistical power was limited in the analyses (online s[upplementary file 3](#SP3){ref-type="supplementary-material"}), thus preventing to derive firm conclusions.

Overall, these studies involving a priori scores provided interesting insights into the relationships between nutrition and breast cancer risk. Although these a priori scores and the FSA-NPS DI included similar nutritional components, the approaches differed, making the comparison between our study and previous findings not straightforward (even though our results were in line with those obtained with scores measuring the adherence to cancer-specific nutritional recommendations[@R49]). The FSA-NPS DI is not primarily built at the individual level but is rather derived from a nutrient profiling system at the food level (FSA-NPS) thus taking into account the nutritional quality of each food/beverage consumed and not only of the overall diet or overall consumption of food groups. In addition, the objective behind the FSA-NPS DI construction was not to obtain the best predictive score for breast cancer but to specifically test its association with breast cancer risk, as the FSA-NPS is envisioned to serve as a basis for food labelling in the framework of public health policies in several countries such as France and Australia. The FSA-NPS displays several key advantages in a public health context: (1) it grades the nutritional quality of each food/beverage and thus reflects the variation of nutritional quality between but also within food groups, (2) it has been designed in a perspective of prevention of a large range of chronic diseases (not only breast cancer) and (3) it is easy to compute for industrials and public health stakeholders.

Our results are consistent with current evidence from epidemiological and mechanistic studies regarding the association between nutrition and breast cancer. Most of the input variables for the FSA-NPS are indeed parameters for which associations with breast cancer have been established either directly (eg, dietary fibres[@R53]) or indirectly, through an association with body fatness, a major risk factor for postmenopausal breast cancer[@R53] (eg, energy content, total sugars and SFA as components of energy-dense foods; fruits and vegetables as components of low-energy foods).

In our study, although similar trends were observed in premenopausal and postmenopausal women for the association between the FSA-NPS DI and breast cancer risk, this association was nonetheless stronger in premenopausal women. This may be explained by the fact that premenopausal women were more likely to score high on the FSA-NPS DI, thus resulting in a clearer/stronger association: mean±SD FSA-NPS DI was 6.3±2.3 in premenopausal women (median:6.4, 25th75th percentiles: 4.9--7.8) and 5.5±2.1 in postmenopausal women  (median:5.5, 25th75th percentiles: 4.1--6.9).

Strengths of this study pertained to its prospective design, its large sample size and the assessment of usual dietary intakes using repeated 24-hour dietary records based on a recent food composition database with a large choice of items (\>3300). The latter allowed a better insight into the food products consumed and their intrinsic nutritional quality compared with studies that used a food frequency questionnaire (more aggregated food items). However, some limitations should be acknowledged. First, caution is needed regarding the extrapolation of these results to the entire French population since this study included volunteers involved in a long-term cohort study investigating the association between nutrition and health, with overall more health-conscious behaviours and higher professional and/or educational level compared with the general population. Thus, unhealthy dietary behaviours may have been under-represented in this study, which may have weakened the observed associations. Second, information regarding cancer stage was not available. Third, unlike other a priori scores, components of the FSA-NPS DI cannot be studied separately since (1) the FSA-NPS DI is first calculated at the food level (FSA-NPS) and then aggregated at the individual level and (2) the calculation of the FSA-NPS score (online s[upplementary file 1](#SP1){ref-type="supplementary-material"}) is based on thresholds and conditions that are inter-related between the different score components. Fourth, as usually done in nutritional epidemiology, dietary intakes were estimated based on averaged intakes from all 24-hour dietary records collected over the first 2 years of follow-up. Although diet may change over time, it is usually hypothesised that this estimation reflects general eating behaviour throughout the adult life.[@R56] This very classical method allowed us to obtain a reliable estimation of usual dietary intakes, while respecting the prospective design (ie, estimation of usual dietary intakes prior to cancer diagnosis). Indeed, breast cancer is a disease with relatively long latency so that the involvement of nutritional factors is supposed to be based on long-term processes. Thus, it is important to guarantee sufficient delay between nutritional exposure and cancer outcome. This is why we tested a model (sensitivity analysis) where cancer cases diagnosed during the first year of follow-up were excluded (similar results). In our study, although the follow-up time was appropriate to perform etiological analyses, it did not necessarily guarantee this sufficient delay. Hence, our estimation of usual dietary intakes may reflect dietary protective and risk factors that may have played a role in the first steps of carcinogenesis (initiation) but also later in the carcinogenic process (progression). Nonetheless, previous studies with longer follow-up observed associations between diet and breast cancer risk, suggesting that nutritional factors could play a role in cancer initiation and not only in cancer progression.[@R45] Finally, this study was based on an observational cohort and thus residual confounding cannot be entirely ruled out even though a wide range of confounding factors were taken into account.

In conclusion, the FSA-NPS has been designed to characterise the nutritional quality of foodstuffs and to highlight products with a good nutritional profile that should be promoted and products with a lower nutritional quality that should not. The results of this observational study suggest that the self-declared consumption of food products of lower nutritional quality (as characterised by a higher FSA-NPS) may be associated with an increased risk of breast cancer. Along with other etiological observational studies,[@R19] these findings suggest that this nutrient profiling system might be of interest in the framework of public health nutritional measures such as front-of-pack nutrition labelling or taxes.
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